New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge
Luca Piemontese
摘要：The prevention and treatment of neurodegenerative dis-eases is the new challenge for pharmaceutical industry, but also for public institutions, physicians, patients, and their families. The spread of these pathologies is, in fact, a real social problem, especially in the Western Countries where the population age is increasing and chronic diseases are more and more common. For several of these pathologies, only few drugs have been available for therapies over the years. Alzheimer's disease (AD), for instance, has only five"symptomatic" approved drugs: four of them (tacrine, do-nepezil, rivastigmine, galantamine) are acetylcholinesterase inhibitors, while memantine is a N-methyl-D-aspartate (NMDA) receptor antagonist (Santos et al., 2016).
机标关键词：prevention and treatment
资助基金： I2PCTF6(no della specializzazione intelligente e della sostenibilità sociale ed ambientale - Future In Research". Project ID)
论文发表日期：2017-01-01
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 405-406 )